What does CDAD stand for?

The study will assess the safety and efficacy of Ramoplanin to treat Clostridium difficile-associated diarrhea (CDAD), a serious form of colitis caused by toxins produced by the Gram- positive bacteria Clostridium difficile (C.

Clostridium difficile-associated diarrhea (CDAD) is a common cause of mortality and morbidity in hospitalized patients.

OPT-80 is currently being tested in Phase 3 clinical trials for CDI, also known as Clostridium difficile-associated diarrhea.

OPT-80's selectivity may preserve the natural balance of flora in the gastrointestinal tract in patients with Clostridium difficile-associated diarrhea (CDAD) while eliminating the infection.

Oscient Pharmaceuticals Corporation (Nasdaq: GENE) has completed enrollment of an open-label, Phase II clinical trial of Ramoplanin, a novel, investigational oral antibiotic being developed for the treatment of Clostridium difficile-associated diarrhea (CDAD).

BUSINESS WIRE)--May 12, 2003 Animal Model Demonstrates Increased Potency of Ramoplanin Compared to Current Therapies Researchers at the 13th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), being held in Glasgow, Scotland, May 10-13, 2003, are presenting compelling data on the in vivo activity of Ramoplanin in a hamster model for Clostridium difficile-associated diarrhea (CDAD) or colitis.

The study will assess the safety and efficacy of Ramoplanin to treat Clostridium difficile-associated diarrhea (CDAD), a serious form of colitis caused by toxins produced by the Gram-positive bacteria Clostridium difficile (C.

The Company is now limiting its human passive antibody development efforts to DiffGAMTM bovine anti-Clostridium difficile immunoglobulins, a product intended to treat Clostridium difficile-associated diarrhea ("CDAD") .